DDHA 8600 Walden University Bioethics Health Care Policy and Law Paper

/in /by

1: IRB and the Aging Physician

There have been a series of adverse outcomes in clinical trials being conducted at your hospital. The Medical Director who has headed the Institutional Review Board (IRB) has been doing so for the past 20 years. After further investigation, legal counsel has informed you that the protocols have not been followed, and in many instances, patients have not been provided adequate informed consent. You have also heard rumors that the Medical Director, now aged 71, has noticeably slowed in recent years and at times seems forgetful.

For this Discussion, reflect on the scenario presented. Then, consider how you as a current or future healthcare administration leader might address the issues with IRB in the scenario. Think about what steps might be needed to make an IRB valid and to ensure that research conforms to IRB protocol.

Explain what steps you, as a current or future healthcare administration leader, might take to address the issues with IRB as presented in the scenario. Explain what steps are needed to make an IRB valid and how you would ensure that research in a health services organization conforms to proper IRB protocol. Be specific and provide examples.

  • Analyze implications of improper IRB protocols for health services organizations
  • Analyze healthcare administration leader strategies for ensuring valid IRB protocols

(3-4 pages)


2: Clinical Research and Informed Consent

When entering into a clinical research study, patients are provided with several forms of information detailing the aims of the study as well as any anticipated complications or difficulties they might experience as a participant in the clinical research study. However, if patients are not aware of or do not fully understand the research materials provided, are they truly and adequately informed to enter into the clinical research study?

For this Discussion, think about the importance of informed consent necessary for patients to participate in a clinical research study. As a current or future healthcare administration leader, consider how inadequate informed consent impacts risks for litigation?

Explain and describe the implications of having patients participate in a clinical research study without adequate informed consent. Then, explain how you, as a current or future healthcare administration leader, might address patient concerns about informed consent, including what strategies you might take to reduce risks of litigation.

  • Analyze stakeholder and organizational implications of patients participating in an IRB without informed consent
  • Evaluate strategies healthcare administration leaders might take to reduce risk of litigation in relation to IRB participation without informed consent

(3-4 pages)

Needs help with similar assignment?

We are available 24x7 to deliver the best services and assignment ready within 3-4 hours? Order a custom-written, plagiarism-free paper

Get Answer Over WhatsApp Order Paper Now